Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuro Matano

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Frontiers in Microbiology|June 6, 2022
Diarrhea-Causing Bacteria and Their Antibiotic Resistance Patterns Among Diarrhea Patients From GhanaTheophilus Afum, Diana Asema Asandem, Prince Asare, et al.
Plos Pathogens|July 19, 2021
Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaquesTakushi Nomura, Hiroyuki Yamamoto, Masako Nishizawa, et al.
International Immunology|February 4, 2021
Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in JapanTomohiro Takano, Takayuki Matsumura, Yu Adachi, et al.
Scientific Reports|October 30, 2024
Non-invasive SARS-CoV-2 RNA detection and human transcriptome analysis using skin surface lipidsTetsuya Kuwano, Takayuki Kanno, Minoru Tobiume, et al.
Cell Reports. Medicine|March 2, 2022
Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8<sup>+</sup> T cell responsesHiroshi Ishii, Takushi Nomura, Hiroyuki Yamamoto, et al.
The Journal of Infectious Diseases|January 13, 2017
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost RegimensJulien Nyombayire, Omu Anzala, Brian Gazzard, et al.
Iscience|April 5, 2021
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatmentHirofumi Ohashi, Koichi Watashi, Wakana Saso, et al.
Scientific Reports|July 7, 2021
Gut microbiota signature of pathogen-dependent dysbiosis in viral gastroenteritisTaketoshi Mizutani, Samuel Yaw Aboagye, Aya Ishizaka, et al.
Immunity|July 11, 2021
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variantsSaya Moriyama, Yu Adachi, Takashi Sato, et al.
Journal of the International AIDS Society|May 24, 2023
Association of demographics, HCV co-infection, HIV-1 subtypes and genetic clustering with late HIV diagnosis: a retrospective analysis from the Japanese Drug Resistance HIV-1 Surveillance NetworkMachiko Otani, Teiichiro Shiino, Atsuko Hachiya, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Frontiers in Microbiology|June 6, 2022
Diarrhea-Causing Bacteria and Their Antibiotic Resistance Patterns Among Diarrhea Patients From GhanaTheophilus Afum, Diana Asema Asandem, Prince Asare, et al.
Plos Pathogens|July 19, 2021
Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaquesTakushi Nomura, Hiroyuki Yamamoto, Masako Nishizawa, et al.
International Immunology|February 4, 2021
Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in JapanTomohiro Takano, Takayuki Matsumura, Yu Adachi, et al.
Scientific Reports|October 30, 2024
Non-invasive SARS-CoV-2 RNA detection and human transcriptome analysis using skin surface lipidsTetsuya Kuwano, Takayuki Kanno, Minoru Tobiume, et al.
Cell Reports. Medicine|March 2, 2022
Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8<sup>+</sup> T cell responsesHiroshi Ishii, Takushi Nomura, Hiroyuki Yamamoto, et al.
The Journal of Infectious Diseases|January 13, 2017
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost RegimensJulien Nyombayire, Omu Anzala, Brian Gazzard, et al.
Iscience|April 5, 2021
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatmentHirofumi Ohashi, Koichi Watashi, Wakana Saso, et al.
Scientific Reports|July 7, 2021
Gut microbiota signature of pathogen-dependent dysbiosis in viral gastroenteritisTaketoshi Mizutani, Samuel Yaw Aboagye, Aya Ishizaka, et al.
Immunity|July 11, 2021
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variantsSaya Moriyama, Yu Adachi, Takashi Sato, et al.
Journal of the International AIDS Society|May 24, 2023
Association of demographics, HCV co-infection, HIV-1 subtypes and genetic clustering with late HIV diagnosis: a retrospective analysis from the Japanese Drug Resistance HIV-1 Surveillance NetworkMachiko Otani, Teiichiro Shiino, Atsuko Hachiya, et al.
Pageof 17